Abstract
and ER stress-induced cell death -Protein degradation: the ubiquitin-proteasome system and autophagy -Ubiquitin-proteasome system -Autophagy -Protein aggregation • Towards pro-survival therapies for neurodegenerative diseases aging there is relatively little neuronal loss, which is in contrast to a high degree of neuronal death in neurodegenerative diseases [2] . This review will focus on mechanisms of cell death in neurons and will attempt to bring together some common themes around pro [1] . [3] . There 
Mechanisms of cell death in neuronal cells

Although it is recognized that neurons die in neurodegenerative diseases, the mode of cell death is often unclear. There are a number of recognized ways in which neuronal cells can die, including apoptosis, necrosis, autophagic cell death (ACD) and excitotoxicity. Other forms of cell death such as oncosis and paraptosis have not been studied much in neurons, and a role for these modes of cell death in neurodegenerative diseases is not known, largely because of the lack of specific markers
Necrosis
Necrosis is an acute form of cell death. It is characterized by loss of ATP, dissipation of ion gradients, cell swelling and ultimately cell lysis (Fig. 1A). Necrosis thus causes inflammation in the surrounding region due to release of cell contents into the environment. Necrotic cell death is usually caused by severe cellular stress, e.g. by high levels of toxins. Necrosis is not a programmed form of cell death in that there is no identifiable biochemical pathway, and once initiated, this form of cell death does not offer much potential for therapeutic intervention since it tends to be acute in nature.
Apoptosis
Apoptosis was originally defined as 'shrinkage necrosis', exhibiting condensed and fragmented nuclei in shrunken cells. In contrast to necrosis, apoptosis is characterized by maintenance of cellular ATP and the initiation of a biochemical pathway leading to cell shrinkage, budding off of apoptotic bodies and phagocytosis of these cell particles. There is no associated cell lysis or inflammation. Biochemically, apoptosis is associated with the activation of caspase proteases that exist in a functional hierarchy of initiator and downstream effector caspases (Fig. 1B). Effector caspases cleave a wide variety of protein substrates to cause the degradation and demise of the cell
are at least two well-characterized ways in which caspase activation is initiated in mammalian cells. These are the intrinsic (or mitochondrial) pathway and the extrinsic (or death receptor) pathway.
In the intrinsic pathway, caspase activation is triggered by the release of cytochrome c from the mitochondria into the cytosol, where it plays an essential role in the formation of a multimeric caspase activation complex called the apoptosome [4, 5] . Specifically, cytosolic cytochrome c interacts with Apaf-1 which, in the presence of dATP, leads to clustering and autoactivation of initiator caspase-9 [4, 6] . Active caspase-9 causes cleavage and activation of downstream effector caspases, such as caspase-3. This occurs in response to several apoptotic stimuli including neurotoxins such as colchicine, glutamate, 6-hydroxydopamine [7] [8] [9] . It should be noted that other pro-apoptotic factors such as Smac/Diablo, apoptosis-inducing factor (AIF) and Omi/Htra2 are also released from the mitochondria during apoptosis [10] . One of these, AIF can induce chromatin condensation without caspase activation (Fig. 1C ) and in fact, apoptotic nuclear morphology in neuronal cells is not always associated with caspase activity [11, 12] (Fig. 1B) [13] .
Apoptosis can be regulated at various points in the pathway. Mitochondrial integrity, and thus the intrinsic pathway, is regulated by the Bcl-2 family, which includes both pro-(e.g. Bax, Bak) and anti-apoptotic (e.g. Bcl-2, Bcl-xL) members, which either promote or inhibit release of pro-apoptotic factors into the cytosol (Fig. 1B) [14] [15] [16] [19] . [23, 24] . [8, 19] . The mode of death induced by glutamate has been shown to depend on mitochondrial transmembrane potential (⌬⌿m) [19, 28] . The ⌬⌿m controls three interrelated mitochondrial functions of relevance to neuronal survival: namely, ATP synthesis, Ca 2ϩ accumulation and superoxide generation [29] .
Autophagic cell death
Crosstalk between different cell death mechanisms
During exposure of cerebellar granule cells to glutamate, both ⌬⌿m and ATP levels decline rapidly (Fig. 1C ) [19] . In those neurons with irreversibly dissipated ⌬⌿m, necrosis rapidly ensues, while the surviving population recover both ⌬⌿m and energy levels and subsequently undergo delayed apoptosis [19] . [23] . Conversely, inhibition of autophagy can trigger apoptosis [32] . At [35] . However, the effect of Bcl-2 on autophagy is controversial as it has also been reported to sensitize cells to autophagy and permit autophagy to develop through inhibition of apoptosis [33, 37] . Bcl-2 inhibition of autophagy is mediated through its interaction with Beclin 1 [35] . Beclin [58] . AD mutations lead to altered processing that is accompanied by increased production of a slightly larger peptide, ␤-amyloid-42, which is prone to oligomerization, forming fibrils and placques [59] .
It is uncertain what leads to neuronal cell death in AD.
Studies of post-mortem brain tissue indicate that neuronal apoptosis occurs in AD [60] . Active caspases have been detected in post-mortem tissue from AD brains [61] [62] [63] . However, this has been disputed by others who report no apoptotic morphology in AD cases [64] . In vitro models show that ␤-amyloid can induce apoptosis [65, 66] . Presenilin mutations sensitize neurons to induction of apoptosis and to excitotoxicity [67, 68] . In fact, it has been suggested that accumulation of ␤-amyloid leads to increased sensitivity to excitotoxicity in AD [69] and excessive activation of NMDA receptors has been specifically linked to ␤-amyloid-induced degeneration in a rat model [70] . It has also been suggested that excitotoxicity might have a more important role in later stages of AD [71] . Although autophagy has been linked to models of AD, there is no evidence that this is part of a cell death pathway [72] . [73] . Of these, parkin and UCHL1 are linked to the ubiquitin-proteasome system (UPS) that degrades damaged or misfolded proteins [74] . In addition, several of these genes, including parkin, PINK1, DJ-1 and Omi/Htra2 are linked to the mitochondria, and may have roles in mitochondrial function and resistance to oxidative stress [75] . The molecular mechanisms that initiate dopaminergic neuron loss in PD are not known. Evidence from various sources suggest a role for toxin-induced death, oxidative stress, defects in mitochondrial complex I, protein aggregation and impairment of the UPS [76] [77] [78] .
Parkinson's disease
The presence of apoptotic chromatin clumps along with TUNEL staining in neuromelanin-containing cells in the substantia nigra PD post-mortem tissue suggests that apoptotic cell death contributes to neuronal loss in PD [79] [80] [81] [82] . However, others have been unable to confirm these findings [83, 84] . Activated caspase-3 has also been observed in these cells [81] . There is also evidence for a role for the extrinsic apoptotic pathway in postmortem studies of PD brain. These are related to the increased levels of TNF␣, soluble Fas and the Fas adaptor protein FADD in the midbrain of PD patients [85] [86] [87] . Importantly, increased active caspase-8 has been detected in neuromelanin-containing substantia nigra neurons in PD brains [88, 89] [104, 105] . The disease pathology is characterized by the presence of nuclear inclusions containing mutant huntingtin [106] . [110, 111] . Interestingly, huntingtin itself is a substrate for caspases, generating truncated fragments containing the polyglutamine tract that may be toxic [112] [113] [114] [126] [127] [128] . However, ACD has not been conclusively shown. [129] . In response cells mount the unfolded protein response (UPR) [129] .
Huntington's disease
HD is one of a number of trinucleotide repeat disorders. It is caused by a dominantly inherited expansion of a translated CAG repeat in the N-terminus of the huntingtin protein. The length of the CAG expansion inversely correlates with age of onset of disease symptoms [104]. The main clinical symptom is the occurrence of generalized involuntary movements, which is a consequence of the selective loss of the medium spiny neurons in the neostriatum
Neuronal cell death in HD may be linked to the accumulation of toxic mutated huntingtin fragments since expansion of the huntingtin CAG repeat above 35 results in neuronal cell death [107-109]. Although a number of interacting proteins have been identified, the physiological role of huntingtin is not known. Caspases have been shown to be activated in HD brains
Ischaemia
Ischaemia, or stroke, is an acute condition caused by an interruption in blood supply, leading to localized deprivation of oxygen, glucose and trophic support in the brain. Since neurons are reliant on a constant supply of oxygen and glucose to generate ATP, the loss of ATP during ischaemia causes rapid dissipation of ion gradients, leading to uptake of water and cell swelling, lysis and cell death. Ischaemia is characterized by acute neuronal cell death and delayed death that occurs many days after the initial insult [123, 124]. The initial phase of cell death is necrotic and the delayed death is apoptotic. Neuronal cell death at the ischemic core tends to be necrotic, while in the penumbra region it is apoptotic, suggesting that the severity of the insult determines the mode of cell death [123, 124]. Both phases of cell death can be blocked by antagonism of NMDA receptors [125]. This cell death is excitotoxic and thus shares the same characteristics in terms of a continuum of necrosis and apoptosis being induced [25, 26]. Upregulation of Beclin 1 is observed in the ischemic penumbra, along with and subcellular redistribution of the autophagy marker LC3 to vacuolic structures in ischemic neurons indicating that autophagy is induced during ischaemia
Recurring themes around protein mishandling in neurodegenerative diseases
Key to the prevention and treatment of neurodegenerative diseases is an understanding of the mechanisms that trigger neuronal cell death. Notably, different neurodegenerative diseases, with different causes, genetic mutations, different patterns of neuronal death, often display a number of common features that include ER
In mammalian cells, this is a three-pronged protective strategy resulting in halt of general protein synthesis to reduce the backlog of proteins, induction of Grp78 and Grp94 chaperone proteins to aid folding of proteins already in the system and ER-associated degradation to remove proteins that cannot be refolded by the ER. This concerted cellular response is mediated through three ER transmembrane receptors: pancreatic ER kinase (PERK), activating transcription factor-6 (ATF6) and inositol-requiring enzyme 1 (Ire1) [130]. In resting cells, all three ER stress receptors are maintained in an inactive state through their association with the ER chaperone, Grp78. On accumulation of unfolded proteins, Grp78 dissociates from the three receptors, which leads to their activation and triggers the UPR.
Although UPR activation is primarily a protective response by the cell, if the stress is unresolved, prolonged activation of the UPR may trigger cell death [129] . In fact, in recent years, a third apoptosis pathway has been proposed, whereby ER stress leads to direct activation of initiator caspase-12 that is located at the ER [131] [133, 135] . The details of how UPR signalling is switched from pro-survival to pro-death is unclear and is a subject of much research, reviewed in [129] . Induction of the transcription factor, CHOP, has been shown to be required for ER stress-induced apoptosis [136] . Recently, the attenuation of IRE1 activity by persistent ER stress has been identified as a potential switch [137] [138] . These changes were seen in normal-appearing neurons, suggesting a role for the UPR early in AD neurodegeneration. Furthermore, presenilin-1 and -2 reside in the ER, and AD mutations appear to impair the ER stress response and enhance vulnerability to stressinduced apoptosis [67, 68] . It has also been suggested that presenilin-1 mutations may deregulate ER Ca 2ϩ stores [139] .
Immunoreactivity for phosphorlyated PERK and phosphorylated eIF2␣ has also been detected in neuromelanin-containing dopaminergic neurons in the substantia nigra of PD cases [140] . The phospho-PERK immunoreactivity was colocalized with increased ␣-synuclein immunoreactivity in dopaminergic neurons [140] . In vitro models using two PD mimetic compounds, 6-hydroxydopamine and MPP ϩ , trigger ER stress in dopaminergic neurons [141, 142] . Furthermore, neuronal cultures from PERK knockout mice, display an increased sensitivity to 6-hydroxydopamine [142] , while a null mutation in CHOP results in a reduction in 6-hydroxydopamine-induced apoptosis in vivo [143] . However, protection was not observed in the chronic MPTP model, despite robust expression of CHOP [143] . In trinucleotide repeat disorders such as HD, the intracellular accumulation of polyglutamine triggers ER stress by inhibiting protein degradation and has been linked to the induction of neuronal cell death by N-terminal mutant huntingtin [144] [145] [146] . ER stress is also a factor in neuronal cell death during ischaemia, with upregulation of CHOP [147, 148] .
Protein degradation: the ubiquitin-proteasome system and autophagy
Misfolded or unwanted proteins are degraded within the cell via two pathways. The ubiquitin-proteasome system (UPS) is the main degradatory pathway for the majority of intracellular proteins. This system is linked to ER stress responses since ER-associated degradation feeds proteins into the UPS for degradation. Secondly, autophagy is used by the cell to eliminate unwanted or damaged organelles via lysosomal degradation and can also be used for degradation of proteins.
Ubiquitin-proteasome system
The UPS involves conjugation of ubiquitin to target substrates, followed by destruction of the tagged protein by the 26S proteasome system [149] . [149] . Cells usually contain just one E1, a few E2 and many E3s, the latter of which are specific for just a small number of substrates. Tagged proteins are then degraded into peptides by the proteasome, a barrelshaped, multiprotein, proteolytic complex.
Conjugation of ubiquitin to proteins involves a series of enzyme reactions. Ubiquitin-activating enzyme E1 generates a high-energy intermediate, E1-ubiquitin. Next, E2 enzymes transfer ubiquitin from E1 to E3 ligase that is bound to specific substrates, to which it ligates activated ubiquitin
Alterations in the UPS have been connected to several neurodegenerative diseases [150, 151] . Proteasome inhibition leads to the intracellular accumulation of ubiquitinated proteins and causes cell death [152, 153] . The accumulation of ubiquitin conjugates is often found in protein aggregates, which include the neurofibrillary tangles of AD, Lewy bodies in PD and nuclear inclusions in HD [154, 155] (Fig. 3) . This could be caused by malfunction or overload of the UPS, or from structural changes in specific protein substrates, halting their degradation.
. It is likely that accumulation of ubiquitin conjugates reflects failed attempts by the UPS to remove the damaged/abnormal proteins that have been tagged for destruction
Proteasome activity is impaired in AD [156] . In the brains of some AD patients a mutated ubiquitin with an extra 20 amino acids at its C-terminus has been observed [157] . This mutated ubiquitin forms polyubiquitin chains that cannot be disassembled and potently inhibit proteasomal degradation of proteins to which they are attached [158] . UPS impairment may also play a role in PD. The PD-associated gene parkin is an E3 ligase, involved in the addition of ubiquitin chains to a select number of protein substrates [159, 160] . It is frequently mutated in early onset PD with loss of ligase function and a reduction in degradation of target proteins [159, 161, 162] . One target of parkin is Pael-R (Parkinassociated endothelin receptor-like receptor) and loss of parkin function results in accumulation of Pael-R, ER stress and neuronal cell death [163, 164] . Conversely, overexpression of parkin suppresses ER stress-induced cell death [164] . Parkin is abundantly expressed within mesencephalic dopaminergic neurons that may explain part of their selective vulnerability [159] . Another mutatedin-PD gene, UCH-L1, was originally characterized as a deubiquitinating enzyme [165] . However, it has also been found to act as a ubiquitin ligase [166] and a mono-ubiquitin stabilizer [167] . Discovery of these mutations in genes linked to UPS function has led to the hypothesis that some PD mutations cause aberrant accumulation of substrates that may be toxic [168] . In addition, reports that ␣-synuclein is degraded through the proteasome led to the idea that abnormalities in UPS-mediated degradation of ␣-synuclein underlie PD [169] [170] [171] . Systemic administration of proteasome inhibitors produces pathological features that are similar to those found in PD [172, 173] . However, some groups have been unable to reproduce these results [174] . The intracellular accumulation of polyglutamine in HD inhibits protein degradation and has been linked to the induction of neuronal cell death by N-terminal mutant huntingtin [144] [145] [146] .
Autophagy
Autophagy mediates the intracellular degradation of organelles and protein complexes that are too big to pass through the narrow pore of the proteasome. It is normally associated with nutrient and growth factor deprivation where it promotes cell survival through provision of molecular building blocks [20] . However, it can also be induced by the presence of protein aggregates such as are found in neurodegenerative diseases (Fig. 3) . Three types of autophagy have been described in mammalian cells: macroautophagy, microautophagy and chaperone-mediated autophagy (CMA) [175] . They all share the lysosome as a common end-point, but differ in the substrates targeted, their regulation and the conditions under which they are preferentially activated. In macroautophagy, intracellular components are sequestered by a limiting membrane to form an autophagic vacuole, the autophagosome, that then fuses with lysosomes to degrade the contents [176] . In microautophagy, substrates are directly internalized through invaginations of the lysosomal membrane. CMA is specialized for the degradation of selective substrate proteins that contain a KFERQ (or similar) motif that is recognized by heat shock cognate protein, HSC70, which translocates the proteins into the lysosomes [177] .
Autophagy has been linked to different neurodegenerative diseases. However, it is unclear if this phenomenon is the result of increased autophagic activity, or decreased fusion of autophagosomes with lysosomes [178] . It has been reported that ␤-amyloid generation may occur in autophagic vacuoles [179] . Autophagy is also linked to PD [99, 101] . ␣-Synuclein is degraded by both CMA and the proteasome [180, 181] . Pathogenic ␣-synuclein mutations block CMA-mediated degradation of ␣-synuclein and of other substrates which may underlie the toxic gain-of-function of these mutants [181] . Increased autophagosomes are seen in HD [121] , which may be linked to the processing of huntingtin fragments by autophagy [182] . Autophagic neuronal death may play a role in neonatal brain ischaemia [127, 128] . [185] . Toxicity due to proteasome inhibition can be rescued by autophagy induction [152, 186] . The obvious interpretation is that autophagy upregulation simply provides an alternative route for protein degradation when the UPS is impaired. However, it is also possible that by removing mitochondria from the cell autophagy induction reduces cellular susceptibility to subsequent apoptotic stimuli mediated by the mitochondrial pathway [32, 187] . [189] . It has a tendency to form protein aggregates that are increased in mutant forms of the protein [190, 191] .
Protein aggregation
It is likely that the accumulation of protein aggregates is linked in some way to neurodegeneration. However, a direct link between aggregate formation and cell death has not been shown (Fig. 3) [150, 192] . Macroautophagy-activating drugs such as rapamycin have been shown to increase clearance of aggregate-prone polyglutamine mutant proteins and mutant ␣-synuclein [193, 194] . In fact, in a transgenic HD mouse model, autophagy-enhancing drugs decrease aggregate formation and improved HD-associated behavioural tasks [193] . Thus [195] . For example, focal cerebral ischaemia increases the levels of several classes of Hsps and their corresponding mRNAs [196] . Notably, the inducibility of Hsps decreases with aging, which may contribute to the inability of aged neurons to fully protect themselves from stresses such as protein misfolding, aggregation and oxidative stress [197] . Hsps promote survival via several different mechanisms [198] . They aid in the refolding and/or degradation of misfolded proteins [199] . Hsp27 and Hsp70 can regulate apoptosis through their ability to inhibit release of pro-apoptotic factors from the mitochondria and to interact with key components of the apoptosome [200] [201] [202] [203] [204] . The small Hsps, Hsp27 and ␣B-crystallin can also modulate intracellular redox potential and help maintain cytoskeletal integrity [198] . Hsps can promote survival in models of various neurodegenerative diseases [195] . Hsps reduce neuronal cell death in models of PD. Heat shock (which leads to elevated expression of inducible Hsp27 and Hsp70) is protective in in vitro models of PD [8, 90] while Hsp27 itself is protective against 6-hydroxydopamine-induced apoptosis in vitro [8] . Hsp27 but not Hsp70 is protective against ␣-synuclein-induced cell death in neuronal cells [205] . Viral vector-delivered Hsp70 is protective against MPTP toxicity in an in vivo model of PD [206] . Hsp27 also protects against polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin [207] , while Hsp70 can alter the endosome-lysosomal localization of huntingtin [208] . Hsp70 overexpression is neuroprotective in a model of cerebral ischaemia [209] .
Currently 
